Literature DB >> 23992680

Electroclinical features and long-term outcome of cryptogenic epilepsy in children with Down syndrome.

Alberto Verrotti1, Raffaella Cusmai, Francesco Nicita, Antonella Pizzolorusso, Maurizio Elia, Nelia Zamponi, Elisabetta Cesaroni, Tiziana Granata, Ilaria De Giorgi, Lucio Giordano, Salvatore Grosso, Piero Pavone, Emilio Franzoni, Giangennaro Coppola, Caterina Cerminara, Paolo Curatolo, Salvatore Savasta, Pasquale Striano, Pasquale Parisi, Antonino Romeo, Alberto Spalice.   

Abstract

OBJECTIVE: To describe the electroclinical features and the long-term outcomes of epilepsy in a large cohort of males and females with Down syndrome who developed epilepsy in childhood. STUDY
DESIGN: Subjects with Down syndrome and cryptogenic epilepsy with onset in childhood were identified retrospectively from the databases of 16 Italian epilepsy centers over a 40-year period. For each subject, age at onset of seizures, seizure semiology and frequency, electroencephalography characteristics, treatment with antiepileptic drugs, and long-term clinical and electroencephalography outcomes were analyzed.
RESULTS: A total of 104 subjects (64 males [61.5%], 40 females [38.5%]) were identified. Seizure onset occurred within 1 year of birth in 54 subjects (51.9%), between 1 and 12 years in 42 subjects (40.4%), and after 12 years in 8 subjects (7.7%). Males had a younger age of seizure onset than females. Of the 104 subjects, 51 (49.0%) had infantile spasms (IS), 35 (33.7%) had partial seizures (PS), and 18 (17.3%) had generalized seizures (GS). Febrile seizures were recorded in 5 (4.8%) subjects. Intractable seizures were observed in 23 (22.1%) subjects, including 5 (9.8%) with IS, 8 (44.4%) with PS, and 10 (31.3%) with GS.
CONCLUSION: Cryptogenic epilepsy in Down syndrome may develop during the first year of life in the form of IS or, successively, as PS or GS. Electroclinical features of IS resemble those of idiopathic West syndrome, with a favorable response to treatment with adrenocorticotropic hormone seen. Patients experiencing PS and GS may be resistant to therapy with antiepileptic drugs.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Keywords:  ACTH; AED; Adrenocorticotropic hormone; Antiepileptic drug; CBZ; CLZ; Carbamazepine; Clonazepam; EEG; Electroencephalography; FBM; Felbamate; GS; Generalized seizures; IS; Infantile spasms; LEV; LGS; Lennox-Gastaut syndrome; Levetiracetam; NS; Not significant; PS; Partial seizures; VGB; VPA; Valproic acid; Vigabatrin

Mesh:

Substances:

Year:  2013        PMID: 23992680     DOI: 10.1016/j.jpeds.2013.07.022

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  8 in total

Review 1.  The genetics of the epilepsies.

Authors:  Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

2.  Reflex seizures in a patient with Angelman syndrome and trisomy 21.

Authors:  Edoardo Ferlazzo; Chiara Sueri; Maurizio Elia; Tiziana D'Agostino; Umberto Aguglia
Journal:  Neurol Sci       Date:  2016-03-14       Impact factor: 3.307

Review 3.  Epilepsy and Autism.

Authors:  Ashura W Buckley; Gregory L Holmes
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

4.  Intellectual disability and epilepsy in down syndrome.

Authors:  Diana Barca; Oana Tarta-Arsene; Alice Dica; Catrinel Iliescu; Magdalena Budisteanu; Cristina Motoescu; Niculina Butoianu; Dana Craiu
Journal:  Maedica (Buchar)       Date:  2014-12

5.  A Retrospective Cohort Study of Combined Therapy in West Syndrome associated with Trisomy 21.

Authors:  Luciana de Paula Souza; Beatriz Bagatin Bermudez; Danielle Caldas Bufara; Ana Chrystina de Souza Crippa
Journal:  Child Neurol Open       Date:  2022-10-13

6.  Implications of delayed diagnosis of infantile spasm in a child with Down syndrome.

Authors:  Allison Buterbaugh; Jeannie Visootsak
Journal:  J Pediatr Neurol       Date:  2014

7.  Treatment of Epilepsy Associated with Common Chromosomal Developmental Diseases.

Authors:  Magdalena Budisteanu; Claudia Jurca; Sorina Mihaela Papuc; Ina Focsa; Dan Riga; Sorin Riga; Alexandru Jurca; Aurora Arghir
Journal:  Open Life Sci       Date:  2020-02-28       Impact factor: 0.938

8.  Response to treatment and outcomes of infantile spasms in Down syndrome.

Authors:  Susan Harvey; Nicholas M Allen; Mary D King; Bryan Lynch; Sally A Lynch; Mary O'Regan; Declan O'Rourke; Amre Shahwan; David Webb; Kathleen M Gorman
Journal:  Dev Med Child Neurol       Date:  2022-01-29       Impact factor: 4.864

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.